Australia - Therapeutic Goods (Permissible Ingredients) Determination (No. 4) 2018
Brazil - Questions and Answers: Resolution RDC 242/2018 on Registration of Specific Medicinal Products
Canada - Form: Post-Notice of Compliance Changes: Level III
China - NMPA Notification No.GuoYaoJianYaoGuan 2018/43: Issuance of Regulation on Administration of Export Certificates of Pharmaceutical Products, 09-Nov-2018 (English and Chinese Versions)
Germany - PEI: Information on Clinical Trials in Germany and Europe now Publicly Available
India - Notice No. CDSCO/IT/2018-(22): Uploading Data of Drug Manufacturing Facilities and Approved Drug Formulations on SUGAM Portal-Guidelines Issued
Japan - Notification: PSEHB/PED No. 0927/3: Matters to Consider in Safety and Evaluation of the Quality of Oligonucleotide Therapeutics
Saudi Arabia - Draft Requirements for the Unique Device Identification System
Taiwan - TFDA Notification: List of Drug Material File (DMF)
United Kingdom - Clinical Research: Initiation and Conduct of Clinical Trials
USA - Federal Register: Definition of the Term "Biological Product" - 21 CFR Part 600 (Proposed rule)
Contact us at info@arqon.com.